TY - JOUR T1 - The revolution of pulmonary arterial hypertension JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 361 LP - 363 DO - 10.1183/16000617.0102-2016 VL - 25 IS - 142 AU - Sergio Harari Y1 - 2016/12/01 UR - http://err.ersjournals.com/content/25/142/361.abstract N2 - Once a death sentence, pulmonary arterial hypertension (PAH) came to be treated by heart–lung transplantation [1] followed by double lung transplant after the discovery of the right ventricle's extraordinary capacity for recovery and remodelling (figure 1) [2]. These advances subsequently led to the introduction of continuous intravenous prostacyclin therapy and a radical change in the prognosis of PAH [3], which was followed by oral therapies alone or in combination.If there has been a revolution in medical therapy in recent decades, it is the treatment of PAH http://ow.ly/1RWN305ibQ3 ER -